Astellas Pharma Клинические исследования

Клинические исследования компании Astellas Pharma: фазы, заболевания и опубликованные результаты.

• A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
  Фаза 2 · Prostate Cancer · Идёт, набор закрыт · 22.09.2023
• An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT i
  Фаза 3 · Metastatic Hormone Sensitive Prostate Cancer · Идёт, набор закрыт · 18.11.2023
• Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
  Фаза 2 · Acute Myeloid Leukemia · Завершено · 28.02.2025
• A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia
  Фаза 3 · AML With FLT3 Mutation · Идёт, набор закрыт · 14.01.2025
• A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subje
  Фаза 3 · Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma or Cancer · Идёт, набор закрыт · 27.01.2025
• A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Tre
  Фаза 3 · Acute Myeloid Leukemia · Завершено · 12.09.2025
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBA
  Фаза 3 · Hormone Sensitive Prostate Cancer · Идёт, набор закрыт · 25.03.2024
• Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin P
  Фаза 3 · Urinary Bladder Cancer, Muscle-invasive · Идёт, набор закрыт · 30.06.2026
• A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistan
  Фаза 4 · Metastatic Castration Resistant Prostate Cancer · Завершено · 23.01.2025
• A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors
  Фаза 2 · Locally Advanced or Metastatic Malignant Solid Tumors · Идёт, набор закрыт · 13.04.2026
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothe
  Фаза 3 · Urothelial Cancer · Идёт, набор закрыт · 27.09.2024
• Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
  Фаза 3 · Geographic Atrophy · Завершено · 14.04.2026
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastri
  Фаза 3 · Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma or Cancer · Идёт, набор закрыт · 26.02.2025
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
  Фаза 3 · mCRPC · Идёт, набор закрыт · 17.01.2024
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)
  Фаза 2 · Stargardt's Macular Dystrophy · Завершено · 12.03.2026

Исследования по компаниям

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & JohnsonBristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

Все исследования